Tenet Healthcare Co. (NYSE:THC - Free Report) - Zacks Research lowered their Q2 2026 earnings estimates for Tenet Healthcare in a note issued to investors on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $3.33 for the quarter, down from their prior estimate of $3.34. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q3 2026 earnings at $3.08 EPS.
Other analysts have also recently issued research reports about the stock. TD Cowen assumed coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They issued a "buy" rating and a $175.00 target price for the company. StockNews.com raised Tenet Healthcare from a "hold" rating to a "buy" rating in a report on Thursday, March 13th. KeyCorp reduced their price target on Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Truist Financial dropped their price objective on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, Barclays decreased their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $166.41.
Check Out Our Latest Stock Report on THC
Tenet Healthcare Stock Performance
Shares of Tenet Healthcare stock traded down $0.95 during trading hours on Monday, hitting $133.55. 1,108,664 shares of the company were exchanged, compared to its average volume of 1,492,828. The business has a 50-day moving average of $132.51 and a 200-day moving average of $142.15. Tenet Healthcare has a 1 year low of $90.03 and a 1 year high of $171.20. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The stock has a market capitalization of $12.70 billion, a price-to-earnings ratio of 4.14, a P/E/G ratio of 1.02 and a beta of 2.06.
Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.
Insider Activity
In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the business's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.93% of the company's stock.
Hedge Funds Weigh In On Tenet Healthcare
Several institutional investors have recently added to or reduced their stakes in THC. Wealth Enhancement Advisory Services LLC increased its stake in shares of Tenet Healthcare by 10.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,836 shares of the company's stock valued at $1,115,000 after acquiring an additional 827 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Tenet Healthcare during the fourth quarter worth approximately $8,783,000. Forum Financial Management LP raised its stake in Tenet Healthcare by 43.5% during the fourth quarter. Forum Financial Management LP now owns 2,469 shares of the company's stock worth $312,000 after purchasing an additional 749 shares during the period. Neo Ivy Capital Management purchased a new stake in shares of Tenet Healthcare during the 4th quarter valued at $2,773,000. Finally, Vise Technologies Inc. increased its holdings in shares of Tenet Healthcare by 28.4% during the 4th quarter. Vise Technologies Inc. now owns 1,613 shares of the company's stock worth $204,000 after buying an additional 357 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
